Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.

@article{Hatzitolios2004EfficacyOO,
  title={Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.},
  author={Apostolos Hatzitolios and Christos G. Savopoulos and Georgia Lazaraki and Ioannis Sidiropoulos and Persefoni Haritanti and Anastasios Lefkopoulos and Georgia Karagiannopoulou and Valentini Tzioufa and Koliouskas Dimitrios},
  journal={Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology},
  year={2004},
  volume={23 4},
  pages={131-4}
}
AIM To evaluate the efficacy and safety of three hypolipidemic agents in patients with non-alcoholic fatty liver disease associated with hyperlipidemia. METHODS Patients with dyslipidemia (Fredrickson type IIb), asymptomatic persistent transaminasemia lasting 24 weeks, and evidence of hepatic fat infiltration on ultrasonography and liver biopsy were studied. Those with predominant hypertriglyceridemia received omega-3 fatty acids (5 mL thrice daily) (Group A), those with predominant… CONTINUE READING